Peer-influenced content. Sources you trust. No registration required. This is HCN.

Medical XpressLung Cancer Patient Becomes Tumor-Free After Treatment with Sodium Selenite

⚠️ Small Study / Early Comparative Evidence

A published case report described an exceptional response to sodium selenite in advanced progressive lung cancer. Investigators also observed a marked sPD-L1 decrease during treatment.


Clinical Considerations

  • One patient achieved complete tumor disappearance and remained tumor-free for 10 years.
  • The uncontrolled report cannot separate treatment effect from tumor biology, prior therapies, or other factors.
  • The sPD-L1 decline offers mechanistic interest but does not establish immune activation or treatment response.
  • Claims regarding tolerability, affordability, and global applicability require evaluation in larger controlled studies.

Practice Applications

  • Recognize the result as an exceptional case rather than evidence of efficacy.
  • Avoid extrapolating this outcome to selenium supplements or routine cancer care.
  • Interpret sPD-L1 changes as exploratory biomarker observations.
  • Monitor planned clinical studies evaluating selenite in larger populations.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form